<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>BIO SmartBrief</title><description>Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues.&amp;nbsp;Click&amp;nbsp; &lt;a href='http://www.smartbrief.com/bio/index.jsp?sb_code=rss'&gt;here&lt;/a&gt; to subscribe.</description><link>http://www.smartbrief.com/news/bio?sb_code=rss</link><image><url>http://www.smartbrief.com/images/homepage/hed-smartbrief.gif</url><title>BIO SmartBrief</title><link>http://www.smartbrief.com/news/bio?sb_code=rss</link></image><language>en-us</language><lastBuildDate>23 May 2013 08:22:08 CDT</lastBuildDate><item><title>BIO fuel header</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D974A6762-DD4F-486D-9C74-4DB1B1042AF8%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D974A6762-DD4F-486D-9C74-4DB1B1042AF8%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">Over 1,300 leaders in biofuels, biobased products and renewable chemicals will be in Montreal June 16-19 for the 10th Annual &nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D974A6762-DD4F-486D-9C74-4DB1B1042AF8%26brief%3DBIO%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>23 May 2013 08:22:08 CDT</pubDate><category>Header News Item</category></item><item><title>Biotech IPOs are on the rise so far this year</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3DFEAAA1D6-5B88-47E7-AA4C-059E0D940DB5%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3DFEAAA1D6-5B88-47E7-AA4C-059E0D940DB5%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">A growing stock market, low interest rates and a lack of market volatility are driving investors to put money into biotech fi&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3DFEAAA1D6-5B88-47E7-AA4C-059E0D940DB5%26brief%3DBIO%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>23 May 2013 08:22:08 CDT</pubDate><category>Today's Top Story</category></item><item><title>Baxter/Halozyme's HyQvia wins EU nod for immunodeficiencies</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D648CDCDB-83D6-49D8-8490-B4D75B748BD3%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D648CDCDB-83D6-49D8-8490-B4D75B748BD3%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">Baxter International and Halozyme Therapeutics obtained approval from the European Commission to market HyQvia as a replaceme&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D648CDCDB-83D6-49D8-8490-B4D75B748BD3%26brief%3DBIO%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>23 May 2013 08:22:08 CDT</pubDate><category>Health Care &amp; Policy</category></item><item><title>Oncolytics' skin cancer drug hits main goal in trial</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D8845A75B-EE7C-431F-9C82-402E9E6E0A5C%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D8845A75B-EE7C-431F-9C82-402E9E6E0A5C%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">Oncolytics Biotech's experimental cancer drug Reolysin, in combination with carboplatin and paclitaxel, achieved the primary &nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D8845A75B-EE7C-431F-9C82-402E9E6E0A5C%26brief%3DBIO%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>23 May 2013 08:22:08 CDT</pubDate><category>Health Care &amp; Policy</category></item><item><title>HHS partners with GSK on antibiotics for superbugs</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3DC558773B-D28D-46FD-9FDB-5D3E75DD6345%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3DC558773B-D28D-46FD-9FDB-5D3E75DD6345%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">GlaxoSmithKline will work in partnership with HHS' Biomedical Advanced Research and Development Authority to develop new anti&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3DC558773B-D28D-46FD-9FDB-5D3E75DD6345%26brief%3DBIO%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>23 May 2013 08:22:08 CDT</pubDate><category>Health Care &amp; Policy</category></item><item><title>Fat-derived stem cells may be more potent than marrow cells</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D8CD72176-A88E-4459-AAC5-2D61D723B8F2%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D8CD72176-A88E-4459-AAC5-2D61D723B8F2%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">Stem cells collected from bone marrow and fat tissue showed comparable abilities to regulate the immune system, but adipose-d&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D8CD72176-A88E-4459-AAC5-2D61D723B8F2%26brief%3DBIO%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>23 May 2013 08:22:08 CDT</pubDate><category>Health Care &amp; Policy</category></item><item><title>Funding round brings in $15M for Epitomics spinoff</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D3BBA933C-CA31-4889-887D-B09CD7D20EC9%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D3BBA933C-CA31-4889-887D-B09CD7D20EC9%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">Apexigen, which specializes in developing new cancer drugs using rabbit-derived, humanized monoclonal antibodies, secured $15&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D3BBA933C-CA31-4889-887D-B09CD7D20EC9%26brief%3DBIO%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>23 May 2013 08:22:08 CDT</pubDate><category>Company &amp; Financial News</category></item><item><title>Wash. biotech pulls in $34M for aerosol antibiotics trial</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3DDEC57A21-7879-445D-A58D-3116D0C3A867%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3DDEC57A21-7879-445D-A58D-3116D0C3A867%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">A Series B funding round has brought in $34 million for Cardeas Pharma, a Seattle area-based startup led by drug developer Br&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3DDEC57A21-7879-445D-A58D-3116D0C3A867%26brief%3DBIO%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>23 May 2013 08:22:08 CDT</pubDate><category>Company &amp; Financial News</category></item><item><title>Cancer Genetics, Mayo establish venture for cancer diagnostics</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D4F5EBAB7-F598-42CE-9024-8DA56B5991B5%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D4F5EBAB7-F598-42CE-9024-8DA56B5991B5%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">Mayo Clinic and Cancer Genetics have formed a joint venture called OncoSpire Genomics to develop cancer diagnostic tests usin&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D4F5EBAB7-F598-42CE-9024-8DA56B5991B5%26brief%3DBIO%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>23 May 2013 08:22:08 CDT</pubDate><category>Industry Deals</category></item><item><title>Biotech labeling law clears Conn. Senate</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D6258C827-9317-44FB-A61A-F9AFC4835B96%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D6258C827-9317-44FB-A61A-F9AFC4835B96%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">The Connecticut Senate voted 35-1 in support of legislation to label biotech food, making it the second legislative body to d&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D6258C827-9317-44FB-A61A-F9AFC4835B96%26brief%3DBIO%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>23 May 2013 08:22:08 CDT</pubDate><category>Food &amp; Agriculture</category></item><item><title>Targeted R&amp;D investments key to renewable jet fuel development</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D61361DF7-6426-40B0-8D6D-635F12A25D55%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D61361DF7-6426-40B0-8D6D-635F12A25D55%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">Investing in research and development is key to bringing down the cost of renewable jet fuel, according to a study led by the&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D61361DF7-6426-40B0-8D6D-635F12A25D55%26brief%3DBIO%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>23 May 2013 08:22:08 CDT</pubDate><category>Industrial &amp; Environmental</category></item><item><title>Save on energy costs through BIO's newest cost-savings program</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D3F3EF21B-F952-4AC1-A398-41D4D7436A8B%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D3F3EF21B-F952-4AC1-A398-41D4D7436A8B%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">BIO has recently aligned with APPI Energy, an energy consulting firm, to assist member companies with reducing their energy e&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D3F3EF21B-F952-4AC1-A398-41D4D7436A8B%26brief%3DBIO%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>23 May 2013 08:22:08 CDT</pubDate><category>News from BIO</category></item><item><title>You may be disappointed if you fail, but you are doomed if you don't try.</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FquoteDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D9637CEBC-0F26-482A-A33B-A9120E240D2D%26brief%3Dbio%26sb_code%3Drss%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FquoteDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D9637CEBC-0F26-482A-A33B-A9120E240D2D%26brief%3Dbio%26sb_code%3Drss%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">Beverly Sills,American opera singer and opera manager&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FquoteDetails.jsp%3Fissueid%3D1EE6B46A-5ACE-4ED8-B1B9-6728DB52C66D%26copyid%3D9637CEBC-0F26-482A-A33B-A9120E240D2D%26brief%3DBIO%26sb_code%3Drss%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>23 May 2013 08:22:08 CDT</pubDate><category>SmartQuote</category></item></channel></rss>